Skip to main content

E Fund Management Co., Ltd.

SEC CIK
0001842296
Latest filing
Aug 10, 2026

LCTX holding history

Lineage Cell Therapeutics, Inc. in every 13F filed by E Fund Management Co., Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LCTX overviewAll 13F holders of LCTXFull Q2 2026 holdings

Shares (Q4 2021)
0
Sold out in Q4 2021
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q3 2021
Holdings of LCTX by E Fund Management Co., Ltd., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20210$00.0%−11,095−100.0%Sold outHolders
Q3 202111,095$28.0K<0.1%–No prior filingHolders